05th week of 2019 patent applcation highlights part 26 |
Patent application number | Title | Published |
20190031674 | QUANTIFICATION AND PREPARATION OF PHARMACEUTICAL GRADE CANTHARIDIN | 2019-01-31 |
20190031675 | AMINOACID DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2019-01-31 |
20190031676 | ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES | 2019-01-31 |
20190031677 | AMMONIUM DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2019-01-31 |
20190031678 | SALT FORM OF DPPIV INHIBITOR AND PREPARATION METHOD THEREOF | 2019-01-31 |
20190031679 | NOVEL MONOTHIOL MUCOLYTIC AGENTS | 2019-01-31 |
20190031680 | COMPOUNDS FOR US IN ANTIBACTERIAL APPLICATIONS | 2019-01-31 |
20190031681 | 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | 2019-01-31 |
20190031682 | DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES | 2019-01-31 |
20190031683 | RAPAMYCIN ANALOGS AND USES THEREOF | 2019-01-31 |
20190031684 | MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS | 2019-01-31 |
20190031685 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | 2019-01-31 |
20190031686 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | 2019-01-31 |
20190031687 | NOVEL POLYMORPHS | 2019-01-31 |
20190031688 | ORGANOBORON COMPOUNDS AND METHODS OF MAKING ORGANOBORON COMPOUNDS | 2019-01-31 |
20190031689 | ALPHA-SILANE COUPLING AGENT AND APPLICATION THEREOF | 2019-01-31 |
20190031690 | ORGANOSILICON COMPOUND AND PRODUCTION PROCESS THEREFOR | 2019-01-31 |
20190031691 | HYDROPHILIC SILANES | 2019-01-31 |
20190031692 | COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2019-01-31 |
20190031693 | COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2019-01-31 |
20190031694 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | 2019-01-31 |
20190031695 | Methods and Compositions for Substituted Alpha-Aminophosphonate Analogues | 2019-01-31 |
20190031696 | COMPOUND AND USE THEREOF AND PLATINUM COMPLEX AND LIPIDOSOME THEREOF | 2019-01-31 |
20190031697 | PHOSPHINE SUBSTITUTED FERROCENYL COMPLEX | 2019-01-31 |
20190031698 | SEPARATION OF OLIGOSACCHARIDES FROM FERMENTATION BROTH | 2019-01-31 |
20190031699 | COMPOUND CONTAINING DEXPANTHENOL | 2019-01-31 |
20190031700 | Modified hexa-acylated neisserial LPS | 2019-01-31 |
20190031702 | Compounds and Methods for the Synthesis of 5-(N-Protected-Tryptaminocarboxyamide)-2'-Deoxyuridine Phosphoramidate for Incorporation into a Nucleic Sequence | 2019-01-31 |
20190031703 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | 2019-01-31 |
20190031704 | MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA | 2019-01-31 |
20190031705 | MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA | 2019-01-31 |
20190031706 | MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA | 2019-01-31 |
20190031707 | Synthesis of Protected 3'-Amino Nucleoside Monomers | 2019-01-31 |
20190031708 | CYCLIC DINUCLEOTIDES FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY SUCH AS CANCER | 2019-01-31 |
20190031709 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2019-01-31 |
20190031710 | PEPTIDE FRAGMENT CONDENSATION AND CYCLISATION USING A SUBTILISIN VARIANT WITH IMPROVED SYNTHESIS OVER HYDROLYSIS RATIO | 2019-01-31 |
20190031711 | Colostrum Solid Extraction Process | 2019-01-31 |
20190031712 | Use of a PVDF membrane to purify cell-binding agent cytotoxic agent conjugates | 2019-01-31 |
20190031713 | READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT | 2019-01-31 |
20190031714 | GENERATING MULTISPECIFIC ANTIBODY MIXTURES AND METHODS OF USES THEREOF | 2019-01-31 |
20190031715 | PROCESS AND INTERMEDIATES FOR SYNTHESIS OF PEPTIDE COMPOUNDS | 2019-01-31 |
20190031716 | RAPADOCINS, INHIBITORS OF EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 AND USES THEREOF | 2019-01-31 |
20190031717 | MULTI-FUNCTIONAL FUSION POLYPEPTIDE, PREPARATION METHOD THEREOF, AND APPLICATION OF SAME | 2019-01-31 |
20190031718 | Signal Molecules as Cell Penetration Agents | 2019-01-31 |
20190031719 | Soluble Forms of Hendra and Nipah Virus G Glycoprotein | 2019-01-31 |
20190031720 | CHEMICALLY ACTIVATED NANOCAPSID FUNCTIONALIZED FOR CANCER TARGETING | 2019-01-31 |
20190031721 | Soluble Forms of Hendra and Nipah Virus F Glycoprotein and Uses Thereof | 2019-01-31 |
20190031722 | INTERVENTIONS FOR FLAVIVIRUS INFECTIONS | 2019-01-31 |
20190031723 | TRUNCATED GLYCOPROTEIN G OF HERPES SIMPLEX VIRUS 2 | 2019-01-31 |
20190031724 | PAPILLOMAVIRUS CHIMERIC PROTEIN AND APPLICATION THEREOF | 2019-01-31 |
20190031725 | Campylobacter Immunogenic Compositions and Uses Thereof | 2019-01-31 |
20190031726 | MODIFIED MEMBRANE PERMEABILITY | 2019-01-31 |
20190031727 | ORAL ADMINISTRATION | 2019-01-31 |
20190031728 | PROTEIN PRODUCT AND PREPARATION METHOD THEREOF | 2019-01-31 |
20190031729 | NOVEL PROTEINS SPECIFIC FOR LAG-3 | 2019-01-31 |
20190031730 | FORMULATION OF MK2 INHIBITOR PEPTIDES | 2019-01-31 |
20190031731 | BIGLYCAN VARIANT POLYPEPTIDES AND METHODS OF USE | 2019-01-31 |
20190031732 | COMPOSITIONS AND METHODS FOR TREATING CANCERS | 2019-01-31 |
20190031733 | AFFINITY MATURATED T CELL RECEPTORS AND USE THEREOF | 2019-01-31 |
20190031734 | COMPOSITIONS AND METHODS FOR INHIBITING WNT SIGNALING | 2019-01-31 |
20190031735 | VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION | 2019-01-31 |
20190031736 | COMPOSITIONS AND METHODS THAT INVOLVE PROTEIN SCAFFOLDS THAT SPECIFICALLY BIND TO HEPATOCYTE GROWTH FACTOR RECEPTOR | 2019-01-31 |
20190031737 | Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods | 2019-01-31 |
20190031738 | Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods | 2019-01-31 |
20190031739 | PINBALL HERPES ANTIBODY SYSTEM | 2019-01-31 |
20190031740 | COMPOSITIONS COMPRISING AAV EXPRESSING DUAL ANTIBODY CONSTRUCTS AND USES THEREOF | 2019-01-31 |
20190031741 | Human Antibodies to Respiratory Syncytial Virus F Protein and Methods of Use Thereof | 2019-01-31 |
20190031742 | MONOCLONAL ANTIBODIES DIRECTED AGAINST TRIMERIC FORMS OF THE HIV-1 ENVELOPE GLYCOPROTEIN WITH BROAD AND POTENT NEUTRALIZING ACTIVITY | 2019-01-31 |
20190031743 | SCREENING METHODS FOR IDENTIFYING ANTIBODIES THAT BIND CELL SURFACE EPITOPES | 2019-01-31 |
20190031744 | MONOCLONAL ANTIBODY OF HUMAN-DERIVED PROCALCITONIN, AND PREPARATION METHOD AND APPLICATION THEREOF | 2019-01-31 |
20190031745 | Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same | 2019-01-31 |
20190031746 | HUMANIZED ANTIBODY IGG1 | 2019-01-31 |
20190031747 | METHODS OF TREATING HEMOLYTIC DISORDERS COMPRISING ADMINISTERING ANTI-Bb ANTIBODIES | 2019-01-31 |
20190031748 | CGRP ANTIBODIES AND USES THEREOF | 2019-01-31 |
20190031749 | SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN | 2019-01-31 |
20190031750 | OPTIMIZED VARIANTS OF ANTI-VEGF ANTIBODIES | 2019-01-31 |
20190031751 | EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE | 2019-01-31 |
20190031752 | Method for Producing Antibodies | 2019-01-31 |
20190031753 | HUMANIZED ANTI-IL-18 ANTIBODIES | 2019-01-31 |
20190031754 | ROR2 ANTIBODY COMPOSITIONS AND RELATED METHODS | 2019-01-31 |
20190031755 | NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES | 2019-01-31 |
20190031756 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER | 2019-01-31 |
20190031757 | METHODS FOR ENHANCING THE POTENCY OF THE IMMUNE CHECKPOINT INHIBITORS | 2019-01-31 |
20190031758 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS | 2019-01-31 |
20190031759 | CHIMERIC ANTIGEN RECEPTORS AND METHODS OF THEIR USE | 2019-01-31 |
20190031760 | ASPGR ANTIBODIES AND USES THEREOF | 2019-01-31 |
20190031761 | ANTIBODY AGAINST EGFRVIII AND USE THEREOF | 2019-01-31 |
20190031762 | POSTERIOR OCULAR FIBROSIS INHIBITION BY ANTAGONIZING PLACENTAL GROWTH FACTOR | 2019-01-31 |
20190031763 | HUMAN MONOCLONAL ANTIBODIES THAT BIND CXCR4 AND USES THEREOF | 2019-01-31 |
20190031764 | Methods of Engineering Surface Charge for Bispecific Antibody Production | 2019-01-31 |
20190031765 | COMBINATION OF AN OX40 AGONIST AND A 4-1BB AGONIST MONOCLONAL ANTIBODY FOR TREATING CANCER | 2019-01-31 |
20190031766 | ANTIBODY MOLECULES TO CD73 AND USES THEREOF | 2019-01-31 |
20190031767 | ANTI-C10ORF54 ANTIBODIES AND USES THEREOF | 2019-01-31 |
20190031768 | ANTI-C10ORF54 ANTIBODIES AND USES THEREOF | 2019-01-31 |
20190031769 | ANTI-CANCER ANTIBODIES WITH REDUCED COMPLEMENT FIXATION | 2019-01-31 |
20190031770 | INTERCALATED SINGLE-CHAIN VARIABLE FRAGMENTS | 2019-01-31 |
20190031771 | HUMAN MONOCLONAL AUTOANTIBODIES TO ADAMTS13 AND USES THEREOF | 2019-01-31 |
20190031772 | METHODS FOR TREATING AND MONITORING THE STATUS OF CANCER | 2019-01-31 |
20190031773 | INHIBITORS AND ANTAGONISTS OF HUMAN PYCR1 | 2019-01-31 |
20190031774 | METHODS FOR TREATING HYPERLIPIDEMIA IN DIABETIC PATIENTS BY ADMINISTERING A PCSK9 INHIBITOR | 2019-01-31 |